The immune checkpoints, such as programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) and cytotoxic T lymphocyte antigen 4 (CTLA-4), are known to help solid tumors evade host anti-tumor immunity. The gene discussed is PDCD1; the disease is neoplasm.